Proteomic Assessment of Preterm Birth (PAPR)

Sera Prognostics

Status: Completed

Conditions: Preterm Birth

Study type: Observational

Funder types: Industry

Identifiers

NCT01371019

Sera - 004

Details and patient eligibility

About

The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.

Enrollment: 5,500 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject is 18 years or older.
• Subject has a singleton pregnancy.
• Subject is able to provide consent.

Exclusion criteria

• Subject is pregnant with more than one fetus.
• There is a known or suspected fetal anomaly.

Trial design

5,500 participants in 2 patient groups

Women with preterm delivery

Women without preterm delivery